Related Experiment Videos
Clonal cytotoxic T cells in myeloma
Daniel M Y Sze1, Ross D Brown, Edna Yuen
1Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. d.sze@centenary.usyd.edu.au
Leukemia & Lymphoma
|December 25, 2003
Summary
Clonal T cells in multiple myeloma (MM) are linked to better patient outcomes. This review details methods for identifying these T-cell receptor (TCR) clones and discusses their role in immunotherapy.
Area of Science:
- Immunology
- Oncology
- Hematology
Background:
- Multiple myeloma (MM) is a cancer of plasma cells in the bone marrow.
- The presence of T-cell receptor (TCR) beta chain rearrangements indicates clonal T cells.
- Clonal T cells in MM are associated with a favorable prognosis.
Purpose of the Study:
- To review methods for detecting clonal T cells in MM.
- To describe the phenotype of these T cell clones.
- To discuss the potential of these CD8+ T cells in immunotherapy.
Main Methods:
- Southern blotting to detect T-cell receptor (TCR) beta chain gene rearrangements.
- Immunophenotyping to characterize T cell populations.
- Analysis of T cell specificities.
Main Results:
- Established methods effectively demonstrate the presence of clonal T cells in MM patients.
- Clonal T cells are predominantly CD8+.
- These T cells exhibit specificities relevant to MM.
Conclusions:
- Clonal T cells, particularly CD8+ populations, are important prognostic markers in MM.
- Understanding the phenotype and specificities of these T cells is crucial for developing novel immunotherapies for MM.